Showing results (21-30 of 265) with videos related to
Sort By:
Pageof 27
Drug Discovery Today. Technologies|January 24, 2014
Rational design of LEDGINs as first allosteric integrase inhibitors for the treatment of HIV infectionBelete A Desimmie, Jonas Demeulemeester, Frauke Christ, et al.Current Gene Therapy|June 13, 2009
Seeing genes at work in the living brain with non-invasive molecular imagingChristophe M Deroose, Veerle Reumers, Zeger Debyser, et al.Molecular Biosystems|December 17, 2008
In search of small molecules blocking interactions between HIV proteins and intracellular cofactorsKatrien Busschots, Jan De Rijck, Frauke Christ, et al.Trends in Biochemical Sciences|January 4, 2015
Host factors for retroviral integration site selectionZeger Debyser, Frauke Christ, Jan De Rijck, et al.Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 22, 2015
Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selectionJonas Demeulemeester, Jan De Rijck, Rik Gijsbers, et al.Current Topics in Medicinal Chemistry|September 2, 2015
Targeting Virus-host Interactions of HIV ReplicationCaroline Weydert, Jan De Rijck, Frauke Christ, et al.BMC Biotechnology|July 14, 2006
Comparison of lentiviral vector titration methodsMartine Geraerts, Sofie Willems, Veerle Baekelandt, et al.Journal of Biomolecular Screening|February 17, 2012
Development of an AlphaScreen-based HIV-1 integrase dimerization assay for discovery of novel allosteric inhibitorsJonas Demeulemeester, Cristina Tintori, Maurizio Botta, et al.Journal of Virus Eradication|March 10, 2017
Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infectionSuha Saleh, Lenard Vranckx, Rik Gijsbers, et al.Viruses|December 28, 2018
Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV InfectionZeger Debyser, Gerlinde Vansant, Anne Bruggemans, et al.Pageof 27